Related Experiment Video
Updated: Aug 6, 2026

06:30
A Novel Contralateral Axillo-Bilateral-Breast Approach for Endoscopic Thyroid Surgery
Published on: July 28, 2026
Operative performance evolution in robotic transaxillary thyroidectomy: an 884-case institutional experience
Mor Shaked Shukrun1,2, Aiman Elmograbi3,4, Patrick Aïdan5
1Department of Otolaryngology-Head and Neck Surgery, Rabin Medical Center, Zeev Jabotinsky Street 39, Petah Tikva, 4941492, Israel. shukrun.mor@gmail.com.
Journal of Robotic Surgery
|July 20, 2026
Summary
Robotic transaxillary thyroidectomy (RTAT) shows improved operative times and reduced complications as programs mature. This approach safely expands to treat more complex thyroid conditions without increasing major risks.
Area of Science:
- Surgical Oncology
- Endocrine Surgery
- Robotic Surgery
Background:
- Remote-access thyroidectomy via the robotic transaxillary approach (RTAT) offers scarless surgery and a magnified operative field.
- The evolution of high-volume RTAT programs, including case acquisition and expansion of indications, is not well-characterized in Western literature.
Purpose of the Study:
- To analyze the institutional lifespan evolution of a high-volume robotic transaxillary thyroidectomy (RTAT) program.
- To assess changes in operative time, complication rates, and surgical indications over program phases.
Main Methods:
- Retrospective analysis of 884 consecutive RTAT procedures at a single tertiary referral center.
- Cases stratified into early (1-295), middle (296-589), and late (590-884) chronological phases.
- Comparison of operative extent, operative time, conversion rate, and complications across eras; multivariable regression for operative time predictors.
Main Results:
- Mean operative time decreased from 159.7 min (early) to 133.4 min (middle) (p<0.001).
- Total thyroidectomy rates increased (42.0% to 50.0%), as did malignancy proportion (8.5% to 14.9%).
- Access-specific morbidity, including transient RLN weakness and brachial plexopathy, significantly decreased over time; no permanent RLN injury or hypoparathyroidism occurred.
Conclusions:
- Operative time and access-specific morbidity declined significantly with program maturation in RTAT.
- The RTAT program safely broadened indications to include more bilateral resections and oncological disease.
- Findings support staged RTAT program development at experienced centers, highlighting safety and efficiency gains.

